07:56 AM EDT, 08/27/2024 (MT Newswires) -- Avicanna Inc. ( AVCNF ) , a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products, announced Tuesday the United States Patent and Trademark Office issuance of the Patent covering Avicanna's ( AVCNF ) deep penetrating topical cannabinoid composition and methods for treating musculoskeletal inflammation and pain. We are...

07:58 AM EDT, 08/27/2024 (MT Newswires) -- Philip Morris International ( PM ) said Tuesday it invested $232 million through its Swedish Match affiliate to expand production at its Owensboro, Kentucky, facility, which manufactures ZYN nicotine pouches. The project is expected to create 450 direct jobs and generate a $277 million annual economic impact, with another 410 indirect jobs for...

07:15 AM EDT, 08/27/2024 (MT Newswires) -- Clear Blue Technologies International ( CBUTF ) overnight Monday said its second-quarter net loss narrowed by a third as revenue rose 35%. The company, which creates and manages power products and services for lower cost off-grid and hybrid energy, said the net loss fell to $1.4 million from $2 million last year. The...

07:18 AM EDT, 08/27/2024 (MT Newswires) -- Merck ( MRK ) said Tuesday it has initiated a phase 3 clinical trial to evaluate bomedemstat, an investigational LSD1 inhibitor, for treating essential thrombocythemia in patients who have not previously received cytoreductive therapy. The trial, which is enrolling around 300 patients, will compare bomedemstat to the standard chemotherapy treatment, hydroxyurea. The primary...